Investor Relations

IR Home

Recent Newsmore >
05/10/17
ConforMIS Reports First Quarter 2017 Financial Results
BILLERICA, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2017. Q1 Summary: Total revenue of $20.5 million, up 1% year-over-year on a reported basis and up 2% on a constant curre... 
04/12/17
ConforMIS Announces Positive Results from Customized iTotal PS Total Knee Replacement Comparative Study
First study of iTotal PS customized implants demonstrated more normal kinematics compared with leading off-the-shelf implants BEDFORD, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (Nasdaq:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced results from the first study of its iTotal® PS total knee replacement presented at the 2017 British Association for Surgery of the Knee (BASK) Annual Meetin... 
Upcoming Eventsmore >
05/25/17
ConforMIS, Inc. participating in B. Riley Institutional Investor Conference
remind me days before the event

06/07/17
ConforMIS, Inc. presents at Jefferies Global Healthcare Conference
remind me days before the event

Enter your e-mail address 
IR Contact
Oksana Bradley
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com

Media Contacts
Bill Berry
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Bberry@berrypr.com

Lynn Granito
Berry & Company Public Relations
Phone: (212) 253-8881
E-mail: Lgranito@berrypr.com
Featured Reports
There are currently no items available.
Data provided by Nasdaq. Minimum 15 minutes delayed.